Evidence map›Paper›PMID 40354780›Full record

ArticleACS synthetic biology2025

Optimization of a High-Throughput Screen for Monitoring Disease-Associated Protein Misfolding and Aggregation in Bacteria.

Dafni C Delivoria, Eleni Konia, Ilias Matis, Georgios Skretas

Abstract read
In one paragraph

Article in ACS synthetic biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dafni C DelivoriaInstitute of Chemical Biology, National Hellenic Research Foundation, Athens 11635, Greece.
Eleni KoniaInstitute for Bio-innovation, Biomedical Sciences Research Center "Alexander Fleming", Vari 16672, Greece.
Ilias MatisInstitute of Chemical Biology, National Hellenic Research Foundation, Athens 11635, Greece.
Georgios SkretasInstitute of Chemical Biology, National Hellenic Research Foundation, Athens 11635, Greece.ORCID 0000-0003-1320-9092

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein misfolding and aggregation are central features of a wide range of diseases, including neurodegenerative disorders, systemic amyloidoses, and cancer. The identification of compounds that can modulate protein folding and aggregation is a key step toward developing effective therapies. High-throughput screening methods are essential for efficiently identifying such compounds. In this study, we optimized a previously developed high-throughput genetic screen for monitoring protein misfolding and aggregation in bacteria. This system is based on monitoring the fluorescence of

Indexed as

Escherichia coliHigh-Throughput Screening AssaysAmyloid beta-PeptidesGreen Fluorescent ProteinsHumansProtein AggregatesProtein FoldingSuperoxide Dismutase-1Tumor Suppressor Protein p53Amyloid beta-PeptidesGreen Fluorescent ProteinsProtein AggregatesSOD1 protein, humanSuperoxide Dismutase-1Tumor Suppressor Protein p53amyloid βgreen fluorescent proteinhigh-throughput screeningp53protein aggregationprotein misfolding diseasesSOD1

Identifiers

PMID40354780
PMCPMC12186678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.